Hemophilia therapy: the future has begun
The success story of hemophilia care first began in the 1970s, when the availability of plasma-derived concentrates of coagulation factor VIII (FVIII) and factor IX (FIX) provided efficacious treatment of bleeding in patients with hemophilia A and B. This positive scenario was consolidated in terms...
| Published in: | Haematologica |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2020-03-01
|
| Online Access: | https://haematologica.org/article/view/9274 |